Instil Bio Inc (TIL)

Jul 22, 2025

What drives Instil Bio Inc. stock priceExceptional portfolio growth - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Instil Bio Inc. Stock Analysis and ForecastExplosive earning power - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

What analysts say about Instil Bio Inc. stockFree Investment Portfolio Suggestions - Autocar Professional

Jul 22, 2025

Jul 22, 2025

Is Instil Bio Inc. a good long term investmentConsistent high-performance stocks - jammulinksnews.com

Jul 22, 2025

Jul 20, 2025

Will Instil Bio Inc. stock benefit from interest rate changesSolid Return Trade Selections - Newser

Jul 20, 2025

Jul 20, 2025

(TIL) Proactive Strategies - news.stocktradersdaily.com

Jul 20, 2025

Jul 18, 2025

When is the best time to buy Instil Bio Inc. stockEntry Level Low Risk Picks - Newser

Jul 18, 2025

Jul 15, 2025

Why Instil Bio Inc. stock attracts strong analyst attentionProtected Capital Trading Plan - Newser

Jul 15, 2025

Jul 15, 2025

What makes Instil Bio Inc. stock price move sharplyFree Consultation - Newser

Jul 15, 2025

Jul 15, 2025

How Instil Bio Inc. stock performs during market volatilityTop Growth Low Risk Stocks - Newser

Jul 15, 2025

Jul 02, 2025

Instil Bio stock jumps after FDA clearance of IND application - Investing.com

Jul 02, 2025

Jul 02, 2025

Instil Bio stock jumps after FDA clearance of IND application By Investing.com - Investing.com UK

Jul 02, 2025

Jul 02, 2025

Instil Bio, Inc. Announces U.S. F.D.A. Clearance of Investigational New Drug Application for AXN-2510 - MarketScreener

Jul 02, 2025

Jul 02, 2025

FDA clears Instil Bio’s IND for AXN-2510 cancer therapy - Investing.com

Jul 02, 2025

Jun 30, 2025

Instil Bio: Chasing After Summit And BioNTech, Albeit With Some Hiccups - Seeking Alpha

Jun 30, 2025

Jun 20, 2025

Instil Bio, Inc. (TIL) Is Up 4.07% in One Week: What You Should Know - Nasdaq

Jun 20, 2025

Jun 17, 2025

Wall Street Analysts Think Instil Bio (TIL) Could Surge 246.68%: Read This Before Placing a Bet - MSN

Jun 17, 2025

Jun 11, 2025

Instil Bio (TIL) Enhances Axion Bio Board with New Appointment | - GuruFocus

Jun 11, 2025

Jun 11, 2025

Instil Bio Names John Maraganore, Ph.D., to Board Role - GlobeNewswire

Jun 11, 2025

Jun 11, 2025

Instil Bio Names John Maraganore, Ph.D., To Board - citybiz

Jun 11, 2025

Jun 11, 2025

Instil Bio, Inc. Announces the Addition of John Maraganore, Ph.D., to the Board of Directors of Axion Bio, Inc., Its Wholly-Owned Subsidiary - MarketScreener

Jun 11, 2025

Jun 11, 2025

Instil Bio Names John Maraganore, Ph.D., to Board Role Supporting the Advancement of PD-L1xVEGF Bispecific Antibody Program - Yahoo Finance

Jun 11, 2025

Jun 11, 2025

Former Alnylam CEO Who Built $40B Company Backs Instil Bio's Novel Cancer Drug Program - Stock Titan

Jun 11, 2025

Jun 06, 2025

(TIL) Technical Pivots with Risk Controls - news.stocktradersdaily.com

Jun 06, 2025

Jun 05, 2025

Instil Bio Appoints ‘Seasoned’ Biopharma Exec as Chief Medical Officer - Dallas Innovates

Jun 05, 2025

Jun 05, 2025

H.C. Wainwright reiterates Instil Bio stock Buy rating amid partnership news By Investing.com - Investing.com South Africa

Jun 05, 2025

Jun 05, 2025

Instil Bio (TIL) Receives Reiterated Buy Rating from HC Wainwrig - GuruFocus

Jun 05, 2025

Jun 05, 2025

H.C. Wainwright reiterates Instil Bio stock Buy rating amid partnership news - Investing.com Canada

Jun 05, 2025